Pseudomembranous Colitis

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 39

Pseudomembranous

colitis
Outlines
• Pseudomembranous colitis
• Causative agent
• Risk factors
• Pathogenesis
• Clinical manifestation
• Diagnosis
• Management
Definition
• Pseudomembranous colitis is an inflammatory condition of the colon
characterized by elevated yellow-white plaques that coalesce to form
pseudomembranes on the mucosa.
• Clostridioides (formerly Clostridium) difficile is the causative organism
of antibiotic-associated colitis

• Colonization of the intestinal tract occurs via the fecal-oral route and
is facilitated by disruption of normal intestinal flora (often due to
antimicrobial therapy)
• C. difficile is an anaerobic gram-positive, spore-forming, toxin-
producing bacillus
first described in 1935
NAP1/BI/027 strain
• Produces larger quantities of toxins A and B

• Resistant to fluoroquinolones in vitro

• Produces binary toxin, an additional toxin that is always absent in


other C. difficile strains
• Antibiotic-associated diarrhea and colitis were well established soon
after widespread use of antibiotics

• In 1978, C. difficile was identified as the causative pathogen in the


majority of cases of antibiotic-associated colitis
• Dramatic increases in the incidence and severity of health care-
associated CDI have occurred since 2000, particularly in patients over
age 65.
Risk factors
• Antibiotic use

• Advanced age

• Gastric acid suppression


CLINICAL MANIFESTATIONS
• Diarrhea with colitis

• Nonsevere disease

• Severe and fulminant colitis


• Recurrent disease

• Asymptomatic carriage
• Nonsevere CDI – White blood cell count ≤15,000 cells/mL and serum
creatinine <1.5 mg/dL

• Severe CDI – White blood cell count >15,000 cells/mL and/or serum
creatinine ≥1.5 mg/dL

• Fulminant colitis: Hypotension or shock, ileus, or megacolon


Unusual presentations
• Protein-losing enteropathy

• Extracolonic involvement: Appendicitis, Small bowel involvement,


cellulitis, soft tissue infection, bacteremia, and reactive arthritis
DIAGNOSIS
• should be suspected in patients with acute diarrhea (≥3 loose stools
in 24 hours) with no obvious alternative explanation (such as laxative
use), particularly in the setting of relevant risk factors (including
recent antibiotic use, hospitalization, and advanced age)
• The diagnosis of C. difficile infection is established via a positive
laboratory stool test for C. difficile toxin(s) or C. difficile toxin B gene.

• Ileus and suspected C. difficile infection??


• EIA screening for glutamate dehydrogenase (GDH) antigen and toxins
A and B

• Radiographic imaging: severe illness or fulminant colitis


Lower gastrointestinal endoscopy?

In general, endoscopy may be pursued for circumstances in which an


alternative diagnosis is suspected that requires direct visualization
and/or biopsy of the bowel mucosa.

• May also be helpful for patients with ileus or fulminant colitis in the
absence of diarrhea since it may allow visualization of
pseudomembranes
• Nucleic acid amplification test
• Enzyme immunoassay for C. difficile glutamate dehydrogenase
• Enzyme immunoassay for C. difficile toxins A and B
• Cell culture cytotoxicity assay
• Selective anaerobic culture
Management
• Antibiotic management

• Infection control

• Diarrhea management?
Surgical management
• Total abdominal colectomy

• Partial colectomy?

• Diverting loop ileostomy

• Colonic lavage
Thank you

You might also like